These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9681275

  • 1. Amelioration of neurovascular deficits in diabetic rats by a novel aldose reductase inhibitor, GP-1447: minor contribution of nitric oxide.
    Yoshida M, Sugiyama Y, Akaike N, Ashizawa N, Aotsuka T, Ohbayashi S, Matsuura A.
    Diabetes Res Clin Pract; 1998 May; 40(2):101-12. PubMed ID: 9681275
    [Abstract] [Full Text] [Related]

  • 2. Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.
    Ashizawa N, Yoshida M, Sugiyama Y, Akaike N, Ohbayashi S, Aotsuka T, Abe N, Fukushima K, Matsuura A.
    Jpn J Pharmacol; 1997 Feb; 73(2):133-44. PubMed ID: 9074947
    [Abstract] [Full Text] [Related]

  • 3. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
    Cameron NE, Cotter MA, Hohman TC.
    Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669
    [Abstract] [Full Text] [Related]

  • 4. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR, Dewhurst M, Stevens EJ, Omawari N, Carrington AL, Vo PA.
    Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
    [Abstract] [Full Text] [Related]

  • 5. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N, Kakuta H, Fukasawa H, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K.
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [Abstract] [Full Text] [Related]

  • 6. Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.
    Cameron NE, Cotter MA, Dines KC, Hohman TC.
    J Diabetes Complications; 1996 Feb; 10(1):43-53. PubMed ID: 8639974
    [Abstract] [Full Text] [Related]

  • 7. GP-1447, an inhibitor of aldose reductase, prevents the progression of diabetic cataract in rats.
    Kawakubo K, Mori A, Sakamoto K, Nakahara T, Ishii K.
    Biol Pharm Bull; 2012 Feb; 35(6):866-72. PubMed ID: 22687477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
    Nakamura J, Kato K, Hamada Y, Nakayama M, Chaya S, Nakashima E, Naruse K, Kasuya Y, Mizubayashi R, Miwa K, Yasuda Y, Kamiya H, Ienaga K, Sakakibara F, Koh N, Hotta N.
    Diabetes; 1999 Oct; 48(10):2090-5. PubMed ID: 10512378
    [Abstract] [Full Text] [Related]

  • 16. Neurovascular effects of L-carnitine treatment in diabetic rats.
    Cameron NE, Cotter MA.
    Eur J Pharmacol; 1997 Jan 29; 319(2-3):239-44. PubMed ID: 9042596
    [Abstract] [Full Text] [Related]

  • 17. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats.
    Cameron NE, Cotter MA.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec 29; 352(6):685-90. PubMed ID: 9053742
    [Abstract] [Full Text] [Related]

  • 18. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH, Tomlinson DR.
    Diabetologia; 1983 Nov 29; 25(5):433-8. PubMed ID: 6197336
    [Abstract] [Full Text] [Related]

  • 19. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.
    Calcutt NA, Mizisin AP, Kalichman MW.
    Eur J Pharmacol; 1994 Jan 04; 251(1):27-33. PubMed ID: 8137868
    [Abstract] [Full Text] [Related]

  • 20. Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.
    Cotter MA, Mirrlees DJ, Cameron NE.
    Eur J Pharmacol; 2001 Apr 13; 417(3):223-30. PubMed ID: 11334854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.